Perrigo Israel has four business units in the cities of Ramat Hovav, Yad Eliyahu, Bnei Brak and Yeruham:
Perrigo Israel Pharmaceuticals Limited: Perrigo Israel Pharmaceuticals Limited (PIP) was founded in 1983. Our 450 employees develop and manufacture branded and generic prescription pharmaceuticals as well as over-the-counter (OTC) pharmaceuticals for the U.S., European and Israeli markets.
Research and development, procurement, quality, registration and manufacturing teams combine their unique expertise in the development of advanced topical and selected oral solid dose generic prescriptions, new indications, new dosage forms and combination products.
The unit has full current Good Manufacturing Practices (cGMP) production and is fully compliant with the regulatory requirements of leading health authorities including the FDA, Israel Ministry of Health, and the European Agency for the Evaluation of Medicinal Products.
Perrigo Israel Pharmaceutical Division (PDI): This division markets, sells and distributes generic and OTC pharmaceuticals as well as branded OTC and vitamin and mineral supplement products for the Israeli market. The products are imported or manufactured locally.
PDI was founded in 1961 representing global pharmaceutical companies in Israel and has 100 employees who work in Bnei Brak in sales, marketing, logistics and distribution roles. The division is one of the largest pharmaceutical companies in Israel.
Diagnostic Products: This unit imports, markets, sells and services diagnostic and other medical pharmaceutical products in Israel through exclusive agreements with the leading global manufacturers.
Perrigo Israel ChemAgis API: Founded in 1987, Chemagis develops, manufactures and markets Active Pharmaceutical Ingredients (API) and Finished Dosage Forms (FDF) for generic and branded pharmaceutical companies in more than 25 countries.
The unit’s 300 employees in Israel work in Yad Eliyahu, Ramat Hovav and Bnei Brak. Chemagis’ main production plant is in the Ramat Hovav Industrial Zone in the Negev Desert, about 13 kilometers (eight miles) from Beer Sheva. Chemagis also has subsidiaries outside Israel in India and the U.S.
Chemagis employees possess great strength in complex chemistry, patents and in-depth regulatory expertise and use this expertise to offer tailor-made solutions to meet the individual requirements of customers.
As of 2012, Chemagis holds 25 proprietary patents and has filed for many more. The unit has full current Good Manufacturing Practices (cGMP) production, from grams to multi-ton, and is fully compliant with the regulatory requirements of leading health authorities including U.S. Food and Drug Administration (FDA), the United Kingdom’s Medicines Control Agency, Australia’s Therapeutic Goods Administration, and Canada’s Health Protection Branch.
Perrigo Israel’s key products assist in a broad range of diseases, such as hypertension, chronic pain, cancer, respiratory diseases and muscle relaxation in surgery. With about 1,200 employees and four business units, there are many opportunities to make a difference at a world-class company with Perrigo Israel.